Remove Drug Development Remove Groups Remove HC Remove Life Science
article thumbnail

Accelerator Life Science Partners Launches Biotechnology Startup Company in Singapore with $16M in Series A Commitments

Digital Health Global

With these resources, Automera is well positioned to deploy our AUTAC platform toward the development of potentially transformative therapies.” About Automera Automera is an early-stage company focused on the development of a novel therapeutic approach via autophagy-based targeted protein degradation.